Literature DB >> 27185805

Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.

Muhanad Mohamed1, Connie Clabots2, Stephen B Porter2, Paul Thuras2, James R Johnson3.   

Abstract

Emerging multidrug-resistant (MDR) Gram-negative bacilli (GNB), including Escherichia coli sequence type 131 (ST131) and its resistance-associated H30 subclone, constitute an ever-growing public health threat. Their reservoirs and transmission pathways are incompletely defined. To assess diarrheal stools as a potential reservoir for ST131-H30 and other MDR GNB, we cultured 100 clinical stool samples from a Veterans Affairs Medical Center clinical laboratory (October to December 2011) for fluoroquinolone- and extended-spectrum cephalosporin (ESC)-resistant E. coli and other GNB, plus total E. coli We then characterized selected resistant and susceptible E. coli isolates by clonal group, phylogenetic group, virulence genotype, and pulsotype and screened all isolates for antimicrobial resistance. Overall, 79 of 100 stool samples yielded GNB (52 E. coli; 48 other GNB). Fifteen samples yielded fluoroquinolone-resistant E. coli (10 were ST131, of which 9 were H30), 6 yielded ESC-resistant E. coli (2 were ST131, both non-H30), and 31 yielded susceptible E. coli (1 was ST131, non-H30), for 13 total ST131-positive samples. Fourteen non-E. coli GNB were ESC resistant, and three were fluoroquinolone resistant. Regardless of species, almost half (46%) of the fluoroquinolone-resistant and/or ESC-resistant non-E. coli GNB were resistant to at least three drug classes. Fecal ST131 isolates closely resembled reference clinical ST131 isolates according to virulence genotypes and pulsed-field gel electrophoresis (PFGE) profiles. Thus, a substantial minority (30%) of veterans with diarrhea who undergo stool testing excrete antibiotic-resistant GNB, including E. coli ST131. Consequently, diarrhea may pose transmission risks for more than just diarrheal pathogens and may help disseminate clinically relevant ST131 strains and other MDR GNB within hospitals and the community.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27185805      PMCID: PMC4958215          DOI: 10.1128/AAC.00383-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.

Authors:  Lorena López-Cerero; María Dolores Navarro; Mar Bellido; Almudena Martín-Peña; Laura Viñas; José Miguel Cisneros; Sara Louise Gómez-Langley; Herminia Sánchez-Monteseirín; Isabel Morales; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  J Antimicrob Chemother       Date:  2013-10-11       Impact factor: 5.790

2.  Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

Authors:  D F Sahm; C Thornsberry; D C Mayfield; M E Jones; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?

Authors:  Christa Ewers; Astrid Bethe; Ivonne Stamm; Mirjam Grobbel; Peter A Kopp; Beatriz Guerra; Michael Stubbe; Yohei Doi; Zhiyong Zong; Axel Kola; Katharina Schaufler; Torsten Semmler; Angelika Fruth; Lothar H Wieler; Sebastian Guenther
Journal:  J Antimicrob Chemother       Date:  2014-01-06       Impact factor: 5.790

4.  Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.

Authors:  K Gupta; D Scholes; W E Stamm
Journal:  JAMA       Date:  1999-02-24       Impact factor: 56.272

5.  Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Evgeni V Sokurenko; Veronika Tchesnokova
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

6.  Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.

Authors:  A R Manges; J R Johnson; B Foxman; T T O'Bryan; K E Fullerton; L W Riley
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

7.  Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.

Authors:  Andrew J Denisuik; Philippe R S Lagacé-Wiens; Johann D Pitout; Michael R Mulvey; Patricia J Simner; Franil Tailor; James A Karlowsky; Daryl J Hoban; Heather J Adam; George G Zhanel
Journal:  J Antimicrob Chemother       Date:  2013-05       Impact factor: 5.790

8.  Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.

Authors:  Yasufumi Matsumura; Masaki Yamamoto; Miki Nagao; Gou Hotta; Aki Matsushima; Yutaka Ito; Shunji Takakura; Satoshi Ichiyama
Journal:  J Antimicrob Chemother       Date:  2012-07-26       Impact factor: 5.790

9.  Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing.

Authors:  Siu Ha Lau; Suganya Reddy; John Cheesbrough; Frederick J Bolton; Geraldine Willshaw; Tom Cheasty; Andrew J Fox; Mathew Upton
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

10.  The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups.

Authors:  Olivier Clermont; Julia K Christenson; Erick Denamur; David M Gordon
Journal:  Environ Microbiol Rep       Date:  2012-12-24       Impact factor: 3.541

View more
  2 in total

1.  Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.

Authors:  Daniel J Livorsi; Michihiko Goto; Margaret Carrel; Makoto M Jones; Jennifer McDanel; Rajeshwari Nair; Bruce Alexander; Brice Beck; Kelly K Richardson; Eli N Perencevich
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-19       Impact factor: 4.887

2.  The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.

Authors:  Marie-Hélène Nicolas-Chanoine; Marie Petitjean; Azucena Mora; Noémie Mayer; Jean-Philippe Lavigne; Olivier Boulet; Véronique Leflon-Guibout; Jorge Blanco; Didier Hocquet
Journal:  BMC Microbiol       Date:  2017-03-27       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.